Market Focus Turns to Sandisk, Revolution Medicines, and McKesson Earnings
- August 02nd, 2026
- 183 views
LAS VEGAS, NV / CRWE PRESS RELEASE / August 2, 2026 - Among the companies set to release financial results on Wednesday, August 5, are:
Sandisk Corporation (Nasdaq: SNDK) is scheduled to release its fiscal fourth-quarter and full fiscal year 2026 financial results after the market closes. Wall Street analysts expect earnings of $34.51 per share on revenue of approximately $8.39 billion. $SNDK ended Friday's session at $1,214.83, declining $65.13, or 5.09%.
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on targeted therapies for cancer, will report second-quarter 2026 results following the closing bell. Consensus estimates call for a loss of $2.06 per share on revenue of $15.47 million. $RVMD closed Friday at $187.53, down $4.64, or 2.41%.
McKesson Corporation (NYSE: MCK), one of the largest healthcare supply chain and pharmaceutical distribution companies in the United States, is set to announce first-quarter fiscal 2027 financial results after regular trading concludes. Analysts are forecasting earnings of $9.54 per share on revenue of $103.74 billion. $MCK finished Friday's session at $856.19, slipping $9.32, or 1.08%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026




Member Login